0
Skip to Content
Qalam Health Solutions
Home
Qalam Health Solutions
Home
Home

PROBLEM

The lack of intraoperative margin assessment for bone cancer is an unmet need to reduce local cancer recurrence as it remains well known that insufficient or positive margins are the most significant predictors for increased risk of local recurrence. Intraoperative assessment of marginal bone cancer cells involves examination of the excised tissue by the pathology lab. This process is exhaustive, labor and resource-intensive. Some surgeons tend to remove more bone than needed, causing potential for further disability. Alternatively, removing less bone with positive residual cancer cells on the margins can increase the risk of local cancer recurrence. The surgeon’s challenge is to maintain a balance to achieve cancer free margins within a single surgical procedure while preserving as much functional tissue as possible.

SOLUTION

We are developing an innovative handheld medical device that uses spectroscopy to provide real-time feedback for intraoperative margin assessment of residual cancer cells. The real-time marginal cancer detection will help reduce surgery time, risk of recurrence and disability due to over-cutting of clean bone. The technology will guide surgeons to precisely detect and remove what is needed for cancer-free margins.

C O N T A C T U S

info@qalamhealth.com

Clinical Innovation Platform
Montreal General Hospital, Floor C9
1650 Cedar Avenue, Montreal
Quebec, H3G 1A4